| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | SR 202 |
|---|
| Description | Selective PPARγ antagonist; antidiabetic and antiobesity agent. Attenuates troglitazone-induced PPARγ transcriptional activity (IC50 = 140 μM) without affecting ligand-stimulated PPARα, PPARβ or FXR transcriptional activity. Inhibits PPARγ-dependent adipocyte differentiation and growth in vitro and in vivo. Improves insulin sensitivity in diabetic ob/ob mice and increases HDL levels in rats in vivo. Purity 99%. MW (observed): 358.65 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (4-Chlorophenyl)(dimethoxyphosphinyl)methyl phosphoric acid dimethyl ester. Mifobate |
|---|
| Gene, Accession, CAS # | CAS: 76541-72-5 |
|---|
| Catalog # | 2022/10 |
|---|
| Price | |
|---|
| Order / More Info | SR 202 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|